Literature DB >> 6860719

Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.

M Sato, C C Chen, K Akiyama, S Otsuki.   

Abstract

From a population of 111 patients with chronic methamphetamine (MAP) psychosis, who were treated at ten mental hospitals during the past 3 years, 21 patients were selected for study. Sixteen patients who experienced MAP psychosis again used MAP one or more times after long-term abstinence and experienced acute exacerbation of a paranoid psychotic state which was almost identical to the initial psychotic episode. Four of these patients relapsed following a single MAP reuse of an amount less than that initially used, and one relapsed without evidence of MAP reuse. In eight patients, small doses of neuroleptics, e.g., 3 mg per day of haloperidol, prevented the acute provocation of a psychotic state by MPA reuse. Subsequently, three of these relapsed into a psychotic state following MAP reuse without concurrent haloperidol medication. The clinical data were compared with animal experiments which indicate that chronic MAP use can induce a long-term susceptibility to sensitization to MAP. The positive prophylactic effect of small doses of haloperidol on the acute exacerbation may suggest the participation of dopaminergic supersensitivity as a mechanism for the paranoid psychotic state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860719

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  38 in total

1.  Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.

Authors:  K Ito; T Abekawa; T Koyama
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

3.  Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-04-08       Impact factor: 3.332

4.  Does context influence the duration of locomotor sensitization to ethanol in female DBA/2J mice?

Authors:  Stephen L Boehm; Karen J Goldfarb; Kristen M Serio; Eileen M Moore; David N Linsenbardt
Journal:  Psychopharmacology (Berl)       Date:  2007-11-30       Impact factor: 4.530

5.  Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats.

Authors:  M G Kolta; F M Scalzo; S F Ali; R R Holson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Sensitivity to apomorphine-induced yawning and hypothermia in rats eating standard or high-fat chow.

Authors:  Michelle G Baladi; Yvonne M Thomas; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

7.  Cross-sensitization of the reinforcing effects of cocaine and amphetamine in rats.

Authors:  Yu Liu; Drake Morgan; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

Review 8.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

10.  Event-related potentials in methamphetamine psychosis during an auditory discrimination task. A preliminary report.

Authors:  A Iwanami; I Suga; N Kato; Y Nakatani; T Kaneko
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.